Key Dates
August 21, 2024 - HEAL Initiative: Justice Community Overdose Innovation Network (JCOIN) - Phase II Methodology and Advanced Analytics Resource Center (UM1 Clinical Trial Not Allowed). See RFA-DA-24-068
August 21, 2024 - HEAL Initiative: Justice Community Opioid Innovation Network (JCOIN) Coordination and Translation Center (U2C Clinical Trial Optional). See RFA-DA-24-069
National Institute on Drug Abuse (NIDA)
The National Institute on Drug Abuse intends to promote a new initiative by publishing a notice of funding opportunity (NOFO) to seek applications for research hubs to participate in Phase II of the Justice Community Overdose Innovation Network (JCOIN).
This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.
The NOFO is expected to be published in Fall 2024 with an expected application due date in Winter 2025.
Details of the planned NOFO are provided below.
HEAL Initiative
This NOFO is part of the NIH’s Helping to End Addiction Long-term (HEAL) initiative to speed the development and implementation of scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative will bolster research across NIH to (1) improve treatment for opioid misuse and addiction and (2) enhance pain management. More information and periodic updates about the HEAL Initiative is available at: https://www.nih.gov/research-training/medical-research-initiatives/heal-initiative.
Background
The Justice Community Overdose Innovation Network (JCOIN) has two broad, complementary goals: to build the evidence base for the delivery of substance use disorder (SUD) treatment services for individuals involved in the criminal-legal system, and to build capacity to implement effective services in both criminal-legal and treatment settings. Phase I of JCOIN established a consortium of practitioner-partnered research projects focused primarily on testing strategies to connect individuals to evidence-based opioid use disorder (OUD) treatment at key transition points between the criminal-legal system and the community. Phase I supported 13 multi-site clinical trials and more than 50 additional distinct research protocols including surveys, modeling, dissemination, and pilot studies, supplements, and ancillary projects. The Network was supported by a Coordination and Translation Center (CTC) and a Methodology and Advanced Analytics Resource Center (MAARC).
Given recent evolution of both the epidemiology of the overdose crisis and public policy intended to support overdose prevention efforts, new research is needed to take effective interventions to scale in jails, courts, and community corrections, and to rigorously test new and emerging models for effectively addressing the complex needs of individuals with SUD and/or high overdose risk at earlier points of the sequential intercept model.
JCOIN Phase II will consist of three highly integrated components: Research Hubs that will each execute multi-site implementation or effectiveness trials in one or more segments of the criminal-legal system; a Coordination and Translation Center, which will provide logistical support, capacity building, national stakeholder engagement, and broad dissemination of research results; and a Methodology and Advanced Analytics Resource Center, which will provide a wide array of data and analytic support services.
A NOFO using a cooperative agreement mechanism is anticipated to support JCOIN Phase II Research Hubs in conducting new research projects in the following areas of priority interest:
Research Hubs will be expected to participate in Steering Committee and workgroup activities to support the collective governance of the Network and facilitate cross-hub collaborations and pilot studies.
Funding Information
$20,000,000 in total costs in FY25
11
$1,500,000 in direct costs per year
TBD
Applications are not being solicited at this time.
Inquiries
Please direct all inquiries to:
Carrie Mulford
National Institute on Drug Abuse (NIDA)
Telephone: 301-827-6473
Email: [email protected]